R. Srivastava, S. Singh, Amarjot Singh, P. Rai, Mushtaq Ali
{"title":"Breast cancer related lymphoedema (BCRL): Prevalence and evaluation of risk factors","authors":"R. Srivastava, S. Singh, Amarjot Singh, P. Rai, Mushtaq Ali","doi":"10.15520/IJMHS.V10I06.2997","DOIUrl":null,"url":null,"abstract":"Among cancer related mortality and morbidity, the Breast cancer is commonest causein women worldwide . Despite of improved treatment technique of the breast cancer,the incidence some refractory complications like breast cancer related lymphoedema(BCRL) of corresponding arm has increased ,which is related to treatment modalitieslike axillary staging, axillary irradiation or both . BCRL is an agonizing complicationwhich limits day to day activity of the patient and becomes more relevant as thesurvival after diagnosis of breast cancer increases. Due to lack of standard definitionand standardized criteria for evaluation, the incidence varies. This Cohort study withhistorical cohort and prospective follow-up for 1 year aimed to determine the prevalence, risk factors, influence of axillary staging and locoregional radiotherapy in thedevelopment of BCRL .Methods: From May 2017 to March 2019 , clinical records of 180 Breast cancer patientswere reviewed from 3 different institutes with Stage I to stage III breast cancertreated with BCT(breast conservation surgery ), MRM (Modified Radical Mastectomy) and RT( Radiotherapy) in addition to systemic chemotherapy and the patients werefollowed up till 1 year. Data were recorded in terms of age, menopausal status, bodymass index (BMI) and presence of co-morbid conditions. Difference between bothupper limb circumferences at any level of more than 2 cm was considered as significantlymphoedema. With the help of SPSS software, all the statistical calculationwas done. Results: The prevalence of clinically significant lymphedema was 32.7%.The prevalence of lymphedema was 34% % in patients treated with MRM where asit was 20% in patients treated with Breast conservative surgery. Among sub groupof MRM in which more than 4 LN came to be positive were having significant lymphedema(42%) as compared to less than 4 LN positive patients(21%). It was observedthat BMI(Body mass index), presence of co-morbid conditions and chemotherapywere not significantly associated with BCRL. Post-operative radiotherapy (axillaryirradiation) appears to be an independent risk factor for development of BCRL inmultivariate analysis (P 25kg/m2 patients . Women whounderwent MRM with more than 4 positive lymph nodes had significantly more numberlymphedema patients . Radiotherapy was found to be independent risk factor forthe development lymphedema, suggesting that the combination of axillary staging andradiation therapy puts patient at much higher risk of lymphedema development.Key words: Breast cancer–lymphoedema","PeriodicalId":13590,"journal":{"name":"Innovative Journal of Medical and Health Science","volume":"1 1","pages":"987-992"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovative Journal of Medical and Health Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15520/IJMHS.V10I06.2997","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Among cancer related mortality and morbidity, the Breast cancer is commonest causein women worldwide . Despite of improved treatment technique of the breast cancer,the incidence some refractory complications like breast cancer related lymphoedema(BCRL) of corresponding arm has increased ,which is related to treatment modalitieslike axillary staging, axillary irradiation or both . BCRL is an agonizing complicationwhich limits day to day activity of the patient and becomes more relevant as thesurvival after diagnosis of breast cancer increases. Due to lack of standard definitionand standardized criteria for evaluation, the incidence varies. This Cohort study withhistorical cohort and prospective follow-up for 1 year aimed to determine the prevalence, risk factors, influence of axillary staging and locoregional radiotherapy in thedevelopment of BCRL .Methods: From May 2017 to March 2019 , clinical records of 180 Breast cancer patientswere reviewed from 3 different institutes with Stage I to stage III breast cancertreated with BCT(breast conservation surgery ), MRM (Modified Radical Mastectomy) and RT( Radiotherapy) in addition to systemic chemotherapy and the patients werefollowed up till 1 year. Data were recorded in terms of age, menopausal status, bodymass index (BMI) and presence of co-morbid conditions. Difference between bothupper limb circumferences at any level of more than 2 cm was considered as significantlymphoedema. With the help of SPSS software, all the statistical calculationwas done. Results: The prevalence of clinically significant lymphedema was 32.7%.The prevalence of lymphedema was 34% % in patients treated with MRM where asit was 20% in patients treated with Breast conservative surgery. Among sub groupof MRM in which more than 4 LN came to be positive were having significant lymphedema(42%) as compared to less than 4 LN positive patients(21%). It was observedthat BMI(Body mass index), presence of co-morbid conditions and chemotherapywere not significantly associated with BCRL. Post-operative radiotherapy (axillaryirradiation) appears to be an independent risk factor for development of BCRL inmultivariate analysis (P 25kg/m2 patients . Women whounderwent MRM with more than 4 positive lymph nodes had significantly more numberlymphedema patients . Radiotherapy was found to be independent risk factor forthe development lymphedema, suggesting that the combination of axillary staging andradiation therapy puts patient at much higher risk of lymphedema development.Key words: Breast cancer–lymphoedema
在与癌症相关的死亡率和发病率中,乳腺癌是全世界妇女中最常见的病因。尽管乳腺癌的治疗技术不断提高,但相应臂的乳腺癌相关淋巴水肿(breast cancer related lymphoedema, BCRL)等难治性并发症的发生率有所增加,这与腋窝分期、腋窝放疗或两者兼而有之的治疗方式有关。BCRL是一种令人痛苦的并发症,它限制了患者的日常活动,并且随着乳腺癌诊断后生存率的增加而变得更加重要。由于缺乏标准的定义和标准化的评估标准,发病率各不相同。本队列研究采用历史队列和1年的前瞻性随访,旨在确定BCRL的患病率、危险因素、腋窝分期和局部放疗对BCRL发展的影响。从2017年5月至2019年3月,我们回顾了来自3个不同机构的180例I期至III期乳腺癌患者的临床记录,这些患者在全身化疗的基础上接受了BCT(乳房保留手术)、MRM(改良根治性乳房切除术)和RT(放疗)治疗,随访至1年。数据记录在年龄、绝经状态、体重指数(BMI)和合并症的存在方面。两上肢周长之间任何超过2厘米的差异都被认为是明显的淋巴水肿。在SPSS软件的帮助下,完成所有的统计计算。结果:临床显著性淋巴水肿发生率为32.7%。接受MRM治疗的患者淋巴水肿患病率为34%,而接受乳房保守手术的患者淋巴水肿患病率为20%。在超过4个LN呈阳性的MRM亚组中,有明显的淋巴水肿(42%),而LN小于4个阳性的患者(21%)。BMI(身体质量指数)、合并症的存在和化疗与BCRL无显著相关性。在多变量分析中,术后放疗(腋窝照射)似乎是BCRL发生的独立危险因素(P 25kg/m2)。有4个以上阳性淋巴结的MRM患者有更多的淋巴水肿患者。放射治疗是淋巴水肿发生的独立危险因素,提示腋窝分期和放射治疗相结合会增加患者发生淋巴水肿的风险。关键词:乳腺癌淋巴水肿